Why Diabetes Stock Insulet Fell 13% in March
Shares of Insulet (NASDAQ: PODD), which makes a tubeless insulin pump, declined 12.8% in March, according to data from S&P Global Market Intelligence. The S&P 500 index returned negative 12.4% last month.
Insulet stock has moved 3.6% higher this month through Monday, April 6. The broader market has returned 3.1% so far this month.
The healthcare stock was a huge winner last year, gaining 116%, compared with the S&P 500's 31.5% return. While it's early in 2020, shares are on track to outperform once again. So far this year, through April 6, they've eked out a 0.3% gain. While that's meager, to say the least, it's much better than the S&P 500's negative-17.1% return over this period.
Source Fool.com
